Christopher O. Petersen sold $4,438 of STK
SVP & Asst Secretary at Columbia Seligman Premium Technology Growth Fund, Inc.. 139 shares at an average of $31.91, traded Sep 4, 2025, filed Sep 8, 2025.
Score components
- +15RoleOfficer
- 0Trade size$4k at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +10.9%, 3m +20.2%, 6m +25.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-25-034272, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 4, 2025 | SOpen-market sale Columbia Seligman Premium Technology Growth Fund, Inc. | -139 | $31.91 | $4,438 | 0 | Sep 8, 2025 |
Related signals
Other insiders at Columbia Seligman Premium Technology Growth Fund, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | STKbuy Columbia Seligman Premium Technology Growth Fund, Inc. | Pamela G Carlton director | $3,600 100 shares | - | |
| 43Moderate | STKsell Columbia Seligman Premium Technology Growth Fund, Inc. | Pamela G Carlton director | $65k 2,256 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.